Submitted by J.M. Johnson on Wed, 08/09/2021 - 14:01
Many diseases have their origin in early human development, and today, 8 September 2021, two publications in Nature reveal how researchers from the Human Cell Atlas consortium are advancing understanding of this.
The global Human Cell Atlas (HCA) initiative, involving experts here at the Wellcome - MRC Cambridge Stem Cell Institute, is mapping every cell type in the human body, to transform our knowledge of biology, infection and disease.
A new large-scale study mapped the cells in the human gut from early development through to adulthood, creating the most comprehensive Cell Atlas of the Gut to date.
This revealed that Crohn’s disease may be caused by activation of developmental pathways, and uncovered potential drug targets for treating Crohn’s and other Inflammatory Bowel Diseases. The detailed maps will help explain how the gut forms and functions, and will transform research into intestinal diseases.
The second publication reveals the hugely ambitious plan to create an entire Human Developmental Cell Atlas (HDCA) of all cells that are important for healthy human development. The gut is just one example of the importance of this, and researchers from the Human Cell Atlas Developmental Biological Network and their collaborators worldwide, show how they will chart developing tissues comprehensively in space and time.
Key to understanding what happens in early development and how this can affect health or lead to disease, the HDCA is likely to lead to transformations in healthcare.
A vital resource
Professor Muzlifah Haniffa, a coordinator of the Developmental Biological Network, from Newcastle University and the Wellcome Sanger Institute, and a senior author on both papers, said:
“The Human Developmental Cell Atlas will provide a vital resource to understand many aspects of biology and disease in order to improve human health."
"Our roadmap shows the progress we’ve achieved so far, including creating a gut development atlas, how we plan to overcome challenges to achieve a complete atlas of human development, and how this will be used to understand disease.”
Professor Bertie Göttgens, contributor and Principal Investigator at the Cambridge Stem Cell Institute said:
"New molecular profiling technologies are transforming our ability to analyse human cells including those from patient samples. The roadmap paper outlines how an international community of researchers is hoping to work together to enhance our understanding of how all human organs are formed. Such an understanding will be vitally important for many areas of stem cell medicine, including organ regeneration and repair."
The gut is a complicated tissue made of multiple cell types, and changes enormously during early development. To understand how the gut develops and functions, researchers from the Wellcome Sanger Institute, Newcastle University, University of Cambridge and their collaborators within the Human Cell Atlas, studied more than a third of a million individual gut cells from developing tissue and from child and adult donors.
Using cutting edge single-cell genomics and spatial analysis techniques, the team revealed which genes were active in each cell, and created a highly extensive Gut Cell Atlas, through time and across 12 regions of the intestines.
Rasa Elmentaite, first author on the study from the Wellcome Sanger Institute, said:
“By studying multiple regions of the human gut throughout development, childhood and adulthood we’ve created a unique, detailed map of the healthy human gut. This Gut Cell Atlas reveals complex developmental events, including how the immune and nervous systems develop in the healthy gut, and identifies important differences along the intestines. The data is openly available to other researchers studying the gut, and will undoubtedly contribute to future discoveries.”
The study also included gut biopsy tissue from children with Crohn’s Disease. This, in combination with the data from healthy development, is giving new insights into rare and common diseases of the intestines.
Dr Kylie James, a senior author on the paper, who carried out the work at the Wellcome Sanger Institute, and is now at the Garvan Institute of Medical Research, Australia said:
“This Gut Cell Atlas is already shedding new light on the origins of Crohn’s and other intestinal diseases. For example, we identified three key cells that attract immune cells to form lymphoid tissue during development, and showed that this same developmental pathway may cause Crohn’s Disease. This knowledge is helping researchers identify potential new drug targets for gut diseases.”
Cross-disciplinary community
While the gut atlas is one example of how understanding development can shed light on disease, a mammoth effort is already underway to create an entire Human Developmental Cell Atlas (HDCA), to transform our understanding of health and disease. The detailed roadmap of how researchers from the HCA Developmental Biological Network plan to create these genomic reference maps of cells, tissues and organs during different stages of healthy human development is revealed in a perspective paper in Nature today.
Coordinated across the globe by Professor Muzlifah Haniffa, Professor Sten Linnarsson and Professor Deanne Taylor, the HCA Developmental Biological Network will bring together many teams of researchers worldwide, sharing data and ethics resources. The cross-disciplinary community will analyse and combine data from different stages of development creating 3-dimensional organ and whole embryo maps of development across space and time.
Working towards understanding how tissues develop and grow, more than 600 researchers attended the first HCA Developmental and Pediatric Cell Atlas meeting, 25-27th August 2021. They connected virtually, forging new collaborations and exchanging knowledge, inspiration and ideas, and recordings of the talks are now available.
The Human Developmental Cell Atlas data will be openly available, and will have applications for finding drug targets, engineering human cells for research or screening, and ultimately even as therapeutics for regenerative medicine.
Dr Sarah Teichmann, co-chair of the Human Cell Atlas Organising Committee and Head of Cellular Genetics at the Wellcome Sanger Institute, and an author on both papers, said: